🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Patient-centered summary of the #CheckMate816 neoadjuvant chemo-immunotherapy clinical trial. This is a new treatment for patients with stage 1-3 non-small-cell lung cancer that can be removed by surgery. The summary may be useful for clinicians & patients. #lcsm LUNGevity Foundation

Congratulations Wafik S. El-Deiry, MD, PhD, FACP! Well deserved recognition.

This is a great technology, the acquisition of which was spear-headed by Wafik S. El-Deiry, MD, PhD, FACP and the #Eldeirylab. Looking forward to starting some CTC-based projects in the #Holderlab. Legorreta Cancer Center at Brown University

Check out this editorial by my outstanding colleague Stephanie Graff, MD, FACP, FASCO highlighting the importance of expanding family leave. #healthequity Providence Journal providencejournal-ri.newsmemory.com/?publink=276ce…

Look forward to Tour de Rhody #4. Sign up, ride and help support cancer research in Rhode Island! See you there🚲🚲

Today was a gorgeous day to join the #WalkwLove DrSusanLoveFund with friends old & new. You can always still join us virtually, walking in your own time. bit.ly/3CZXUs8 #bcsm 👟💞

Congratulations Aditi Shastri, MD! So proud of all your outstanding acheivements. WinC - AlinC (Women in Cancer - All in Cancer) Women in Oncology

2 weeks to #ASCO22, here is a list of what we anticipate could be practice changing. Pls add if we left a critical abstract out that could change our treatment s/p ASCO Inspired by Erika Hamilton, MD & Toni Choueiri, MD OncoAlert #BCSM #GISM #LCSM #OncEd #MedTwitter #Sarcoma #GUSM

Check out the new #ASCO Ed book. Interesting piece on the new druggable target KRAS G12C: Inhibition, Resistance Mechanisms, and Moving Beyond. #lcsm ascopubs.org/doi/full/10.12… ascopubs.org/doi/full/10.12…

Was an honor to speak at the #healthequity in Action Webinar LUNGevity Foundation and share finding of our Lung Cancer screening study in the underserved RI communities, successfully addressing barriers. Great conversations and insights Eugene Manley, Jr., Ph.D.! #LCSM

Don't miss the next episode of Lung Cancer Considered with Narjust Florez, MD, FASCO and Stephen V Liu, MD! Finally an in-person WCLC meeting....stay tuned!

Phase 3 IMscin001 study showed non-inferior PK of subcutaneous atezolizumab compared to intravenous infusion in NSCLC with similar safety profile. #LCSM businesswire.com/news/home/2022…’s-Subcutaneous-Formulation-of-Tecentriq-Demonstrates-Positive-Phase-III-Results

Honored to be invited to the #IASLC podcast ‘Lung Cancer Considered’. What an intriguing discussion on Radon with Laura Mezquita and Narjust Florez, MD, FASCO! Legorreta Cancer Center at Brown University Miriam Hospital Rhode Island Hospital

Panel discussion this morning ACS CAN Rhode Island moderated by Stephanie Graff, MD, FACP, FASCO and featuring Hina Khan DaeHee Kim Drs Robert Legare and Medhavi Gupta speaking about clinical and research advances that benefit patients every day in Rhode Island. Legorreta Cancer Center at Brown University Lifespan Office of Research Care New England

Very exciting news and congratulations to the Cures Within Reach awardees including our colleague Sheldon L. Holder Legorreta Cancer Center at Brown University Brown Pathology and Laboratory Medicine BrUOG The Warren Alpert Medical School shiyoko Benedito A. Carneiro, MD, MS Hina Khan Stephanie Graff, MD, FACP, FASCO @drdonsdizon Sean Lawler Sendurai Mani Robert W. Sobol

It was such an honor to be a panelist speaker ACS CAN Rhode Island #riresearchbreakfast moderated by the wonderful Stephanie Graff, MD, FACP, FASCO and talk about the recent innovations, precision medicine, and access to cancer care. Women & Infants Hina Khan DaeHee Kim Care New England

Join us discussing radon and lung cancer in this new episode of Lung Cancer Considered! Laura Mezquita Hina Khan IASLC Dana Farber's EGFR-Mutant Lung Cancer Center Dana-Farber News

Great to join Narjust Florez, MD, FASCO and the IASLC Lung Cancer Considered team in discussing the role of Radon exposure jn Lung Cancer. Tune in to listen to Laura Mezquita and myself!

Excited, proud and looking forward to the 65 #AACR23 #AACR2023 presentations by colleagues from the Legorreta Cancer Center Legorreta Cancer Center at Brown University reflecting many collaborations internal and external (1% of AACR abstracts from the whole world)-they include 43 from #eldeirylab group which